Asymmetric N,O-Centered Stable Diradical Nanoparticles for NIR-II Fluorescence Imaging-Guided Photothermal Tumor Therapy
Bioconjugate Chemistry · 02.11.2026
DOI: 10.1021/acs.bioconjchem.6c00379 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, online erschienen am 02.11.2026. Verfasst von Lei Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Bengbu Medical University, Donghai Road 2600, Bengbu233030, Anhui, P. R. China. Hauptthemen laut MEDLINE: Nanoparticles, Photothermal Therapy, Optical Imaging. Die Arbeit nennt 26 Literaturangaben. Gefördert von: National Basic Research Program of China (973 Program), National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Stable organic radicals provide distinctive open-shell platforms for near-infrared fluorescence, but their use in NIR-II fluorescence imaging-guided photothermal therapy remains limited. Herein, we report an asymmetric N,O-centered Blatter−phenoxyl diradical (BP) and its nanoparticle formulation (BP-NPs), a water-dispersible nanoplatform prepared by encapsulating the BP by an amphiphilic polypeptide P(OEGMA)23−PLys15. BP combines the oxygen-centered phenoxy and the nitrogen-centered Blatter radical units in an asymmetric scaffold, distinguishes it from many carbon-centered radical and symmetric diradical systems, and shows an absolute photoluminescence quantum yield of 0.73%. Variable-temperature 1H NMR, high-resolution mass spectrometry, and variable-temperature EPR spectroscopy were employed to characterize the molecular structure and temperature-dependent open-shell behavior of BP. After encapsulated, the BP-NPs retained broadband visible-to-NIR absorption and NIR-II emission, with an absolute photoluminescence quantum yield of 0.41% in water. Under 808 nm irradiation, BP-NPs showed good photostability and a photothermal conversion efficiency of 27.3%. In vitro studies reveals that the BP-NPs exhibit low dark cytotoxicity but strong light-induced 4T1 cell killing, while the in vivo NIR-II imaging showed efficient tumor accumulation, with the maximum fluorescence signal and tumor-to-background ratio (TBR ≈ 9.3) observed at approximately 24 h post-injection. Photothermal therapy at this window markedly suppressed the tumor growth without obvious treatment-related body-weight loss during the observation period. This work highlights asymmetric phenoxy−Blatter N,O-centered diradical nanoparticles as promising open-shell platforms for NIR-II imaging-guided photothermal therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Bengbu Medical University, Donghai Road 2600, Bengbu233030, Anhui, P. R. China.
- Hefei National Research Center for Physical Sciences at the Microscale, and Department of Chemical Physics, University of Science and Technology of China, Jinzai Road 96, Hefei230026, Anhui, P. R. China.
ORCID-Profile: Lifeng Yan
Förderung
- National Basic Research Program of China (973 Program)
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
Liu, L., Xu, Y., Chen, D., Wang, Y., An, C., Li, X., Chen, G., & Yan, L. (2026). Asymmetric N,O-Centered Stable Diradical Nanoparticles for NIR-II Fluorescence Imaging-Guided Photothermal Tumor Therapy. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.6c00379
Vancouver
Liu L, Xu Y, Chen D, Wang Y, An C, Li X, et al. Asymmetric N,O-Centered Stable Diradical Nanoparticles for NIR-II Fluorescence Imaging-Guided Photothermal Tumor Therapy. Bioconjugate Chemistry. 2026. doi:10.1021/acs.bioconjchem.6c00379
BibTeX
@article{Liu2026,
author = {Liu, Lei and Xu, Yixuan and Chen, Dejia and Wang, Yating and An, Congyan and Li, Xianfei and Chen, Ganxin and Yan, Lifeng},
title = {Asymmetric N,O-Centered Stable Diradical Nanoparticles for NIR-II Fluorescence Imaging-Guided Photothermal Tumor Therapy},
journal = {Bioconjugate Chemistry},
year = {2026},
doi = {10.1021/acs.bioconjchem.6c00379}
}
EUVIMED